Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$2,750,107
-33.91%
Shares
Shares Volume: 49,074 Shares
Average Share Price: $56.04
INSIDER
Yale Catriona
Chief Development Officer (Officer)
reported on Jan 31 2025
traded on Jan 27 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 95,648 |
| PURCHASES/SALES 1Y | 0 / 13 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $488,941 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 0 / 50 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $668,913.82 |
| COMPANY PREVIOUS TRADES |